Compare Mitsubishi UFJ Financial Group Inc. Common Stock (MUFG) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Mitsubishi UFJ Financial Group Inc. Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Mitsubishi UFJ Financial Group Inc. Common Stock trades at $21.68 (market cap $247.53B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.61B). The key difference: Mitsubishi UFJ Financial Group Inc. Common Stock is far larger — about 23.3× Dr. Reddy's Laboratories Ltd Common Stock's market cap, and Mitsubishi UFJ Financial Group Inc. Common Stock pays the higher dividend (2.46%). Which is the better fit depends on your goals — on Pluang, investors hold Mitsubishi UFJ Financial Group Inc. Common Stock for 2 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.
| MUFG | RDY | |
|---|---|---|
Market Cap | $247.53B | $10.61B |
Volume | 3,196,989 | 3,738,869 |
Sector | Financials | Health |
52-Week High | $24.13 | $15.38 |
52-Week Low | $14.77 | $11.38 |
Typical Hold Time | 2 Days | 0 Days |
Enterprise Value | $28.41T | $10.51B |
Dividend Yield | 2.46% | 0.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Mitsubishi UFJ Financial Group Inc. Common Stock
Mitsubishi UFJ Financial Group is a Japanese financial services company providing banking, lending, securities, and asset management services. Its businesses serve individuals, companies, and institutions worldwide.
Read more on MUFG →About Dr. Reddy's Laboratories Ltd Common Stock
Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.
Read more on RDY →
